Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 16b-3

CDXC Stock  USD 7.59  0.13  1.74%   
About 61% of all Chromadex Corp's shareholders are looking to take a long position. The analysis of overall sentiment of trading Chromadex Corp stock suggests that some investors are interested at this time. The current market sentiment, together with Chromadex Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Chromadex Corp stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Chromadex Corp Officer: Interim Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at investing.com
Investing News at Macroaxis
  
Disposition of 82734 employee stock options (right to buy) at 1.52 of Chromadex Corp by Lee Jeong James on 21st of November 2024. This event was filed by Chromadex Corp with SEC on 2025-02-22. Initial filing of beneficial ownership - SEC Form 3

Chromadex Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Chromadex Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Chromadex Corp Fundamental Analysis

We analyze Chromadex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chromadex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chromadex Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Chromadex Corp is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Chromadex Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chromadex Corp stock to make a market-neutral strategy. Peer analysis of Chromadex Corp could also be used in its relative valuation, which is a method of valuing Chromadex Corp by comparing valuation metrics with similar companies.

Peers

Chromadex Corp Related Equities

IPSCCentury Therapeutics   3.85   
0%
46.0%
ANTXAN2 Therapeutics   3.73   
0%
45.0%
XCURExicure   3.55   
0%
43.0%
ACRVAcrivon Therapeutics,   2.65   
0%
32.0%
MNOVMediciNova   1.46   
0%
17.0%
NKTXNkarta   0.77   
0%
9.0%
AVTEAerovate Therapeutics   0.75   
0%
9.0%
KZRKezar Life   0.54   
6.0%
0%
IKNAIkena Oncology   1.16   
14.0%
0%
MLYSMineralys Therapeutics,   1.42   
17.0%
0%
RZLTRezolute   1.44   
17.0%
0%
JANXJanux Therapeutics   1.68   
20.0%
0%
ADAGAdagene   2.20   
26.0%
0%
ELYMEliem Therapeutics   2.91   
35.0%
0%
ANEBAnebulo Pharmaceuticals   4.11   
50.0%
0%
HCWBHCW Biologics   8.20   
100.0%
0%

Complementary Tools for Chromadex Stock analysis

When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
CEOs Directory
Screen CEOs from public companies around the world
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk